Home › Trials › NCT05325710
Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Personalized follow-up to prevent type 2 diabetes

Official title: Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes

Run by GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT05325710 · Data updated 2026-11-12

This study is testing whether personalized support from a nurse can help people at risk of type 2 diabetes in France make lifestyle changes to prevent the disease.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment230 (estimated)
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche
Academic / other
Locations1 site (Biarritz, Aquitaine)
StatusRecruiting
StartedMarch 20, 2022
Main results expectedApril 1, 2028
Study endsApril 1, 2028
Registry record updatedApril 13, 2022
Trial IDNCT05325710 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with a FINDRISC score of 10 or higher who are beneficiaries of the French health insurance system.

Probably not a fit

Patients over 75 years old, those already diagnosed with type 2 diabetes, or individuals with severe health impairments will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness of personalized follow-up interventions in preventing type 2 diabetes among at-risk individuals in France. It targets patients with a FINDRISC score of 10 or higher, indicating a higher likelihood of developing diabetes. The intervention involves support from a study nurse to guide lifestyle changes and monitor health. The study seeks to address the underdiagnosis of diabetes and the rising prevalence of the condition due to lifestyle factors.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of type 2 diabetes among at-risk populations.

How similar studies have gone: Other studies have shown promise in using personalized interventions for diabetes prevention, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patient, male or female, over the age of 18
* Patient with a FINDRISC score ≥10 points
* Beneficiary of a French health insurance system
* Patient having been informed and having given their consent free, enlightened and written

Exclusion Criteria:

* Patient over 75 years old
* Patient already diagnosed with type 2 diabetes
* Patient whose physical and/or psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.
* Patient participating in another research
* Patient in period of exclusion from another research always in progress at the time of inclusion.
* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration.
* Pregnant, breastfeeding or parturient women.
* Patient hospitalized without consent

Where it's running

  • Clinique Aguiléra
    Biarritz, Aquitaine, France     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Diabete Type 2 24GCS Ramsay Santé pour l'Enseignement et la Recherche 62
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.